Pharmaceutical products (Франция - Тендер #46225729)

1. Section I
   1. Name and addresses
      centre hospitalier saint brieuc
      10, rue Marcel Proust
      Saint-Brieuc
      22027
      France
      E-mail: correspondre@aws-france.com
      
   2. Type of the contracting authority:
      Other type: autre
      
   3. Main activity:
      Health
      
2. Section II
   1. Scope of the procurement:
      1. Title:
         

         ao Medicaments De Cancerologie Relance 2023/2024

         Reference number: 23a509
         
      2. Main CPV code:
         33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000
         
      3. Type of contract:
         Supplies
         
      4. Short description:
         

         consultation lancée par un groupement de commandes.L"accord-cadre sera exécuté par l"émission de bons de commande.Chaque lot fera l"objet d"une attribution séparée.Les prestations sont réglées par des prix unitaires.Ao Medicaments De Cancerologie Relance 20232024du 15 juillet 2023 au 31 mai 2024

      5. Information about lots:
         This contract is divided into lots: yes
      6. Total value of the procurement:
         Value excluding VAT: 3 814 500.00 EUR
   2. Description
      1. Title:
         

         azacitidine

      2. Additional CPV code(s):
         33600000
         
      3. Place of performance:
         Main site or place of performance:

         établissements listés en annexe au Cctp 22000 Saint-Brieuc

      4. Description of the procurement:
         

         azacitidine

      5. Award criteria:
         Cost criterion - Weighting: 1
         
      6. Information about options:
         Options: no
      7. Information about European Union funds:
         The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:
         
      9. Title:
         

         bendamustine Tout Dosage

      10. Additional CPV code(s):
          33600000
          
      11. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      12. Description of the procurement:
          

          bendamustine Tout Dosage

      13. Award criteria:
          Cost criterion - Weighting: 1
          
      14. Information about options:
          Options: no
      15. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      16. Additional information:
          
      17. Title:
          

          bortezomib

      18. Additional CPV code(s):
          33600000
          
      19. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      20. Description of the procurement:
          

          bortezomib

      21. Award criteria:
          Cost criterion - Weighting: 1
          
      22. Information about options:
          Options: no
      23. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      24. Additional information:
          
      25. Title:
          

          cabazitaxel

      26. Additional CPV code(s):
          33600000
          
      27. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      28. Description of the procurement:
          

          cabazitaxel

      29. Award criteria:
          Cost criterion - Weighting: 1
          
      30. Information about options:
          Options: no
      31. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      32. Additional information:
          
      33. Title:
          

          carmustine

      34. Additional CPV code(s):
          33600000
          
      35. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      36. Description of the procurement:
          

          carmustine

      37. Award criteria:
          Cost criterion - Weighting: 1
          
      38. Information about options:
          Options: no
      39. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      40. Additional information:
          
      41. Title:
          

          cyclophosphamide

      42. Additional CPV code(s):
          33600000
          
      43. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      44. Description of the procurement:
          

          cyclophosphamide

      45. Award criteria:
          Cost criterion - Weighting: 1
          
      46. Information about options:
          Options: no
      47. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      48. Additional information:
          
      49. Title:
          

          doxorubicine

      50. Additional CPV code(s):
          33600000
          
      51. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      52. Description of the procurement:
          

          doxorubicine

      53. Award criteria:
          Cost criterion - Weighting: 1
          
      54. Information about options:
          Options: no
      55. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      56. Additional information:
          
      57. Title:
          

          methotrexate

      58. Additional CPV code(s):
          33600000
          
      59. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      60. Description of the procurement:
          

          methotrexate

      61. Award criteria:
          Cost criterion - Weighting: 1
          
      62. Information about options:
          Options: no
      63. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      64. Additional information:
          
      65. Title:
          

          mitosantrone

      66. Additional CPV code(s):
          33600000
          
      67. Place of performance:
          Main site or place of performance:

          établissements listés en annexe au Cctp 22000 Saint-Brieuc

      68. Description of the procurement:
          

          mitosantrone

      69. Award criteria:
          Cost criterion - Weighting: 1
          
      70. Information about options:
          Options: no
      71. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      72. Additional information:
          
3. Section IV
4. Description:
   1. Type of procedure:
      Open procedure
   2. Information about a framework agreement or a dynamic purchasing system:
      The procurement involves the establishment of a framework agreement
   3. Information about electronic auction:
      
   4. Information about the Government Procurement Agreement (GPA):
      The procurement is covered by the Government Procurement Agreement: yes
5. Administrative information:
   1. Previous publication concerning this procedure:
      Notice number in the OJ S: 2023/S 097-304421
      
   2. Information about termination of dynamic purchasing system:
      
   3. Information about termination of call for competition in the form of a prior information notice:
      

Источник закупки

Импорт - Экспорт по стране Франция